In all, our data first demonstrated that circ_0001825 contributed to the viability and osteogenic differentiation in hMSCs via activating SMAD5 through sequestering miR-1270, providing a new insight into the development of circRNA-based therapeutics in osteoporosis intervention. Here, SMAD5 is linked to osteoporosis.